Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good interview between two friends.
BANKRUPTCY IS A REAL POSSIBILITY HERE !
I would advise any new prospective "buyer" of this stock to look at ALL of the
posts here from the past FEW years as this stock has gone down from the high
of $5.82 to 2 cents and has been meandering lately with quite low volume between
3 cents and 5 cents area.
The company continues to lose money every year and this past year had a 10.5MM
dollar deficit, defaulted debt in litigation, lack of revenue such that they are operating
off the CEO's own personal credit card (as a loan at interest) and has right at 78 MILLION
outstanding shares.
The company can't get any financing due to the default on a past loan, they can't generate any
revenue from the sale of stock as they are in litigation, and they continue to have a very bloated
pay structure.
Anyhow - BUYER BEWARE.
Interview with Nancy Duitch, CEO, Avenir Wellness Solutions, Inc. (OTC: AVRW)
May 3, 2024
Nancy Duitch serves as the CEO of Avenir Wellness Solutions. With over three decades of experience in the consumer products sector, Nancy has cultivated a diverse array of businesses, guiding them from inception to the public market. Her expertise extends to orchestrating cutting-edge marketing and branding initiatives, resulting in a staggering $3 billion in revenue for esteemed brands. From her early years, Nancy exhibited a clear vision and pursued it with determination. Her knack for crafting iconic brands for infomercials and direct-to-consumer channels has solidified her position as one of the most sought-after female CEOs in the industry. Join us as we delve into Nancy's journey, experiencing her infectious energy and enthusiasm as a lifelong entrepreneur who truly lives life to the fullest.
Exactly - something is ROTTEN / SHADY HERE
Taken from the latest 10K
Salaries and Wages
Salaries and wages expense increased by $494 thousand during the year ended December 31, 2023 as compared to the year ended December 31, 2022. The increase was primarily due to the increase in the number of employees during the year ended December 31, 2023 compared to the same period in 2022.
Selling, General and Administrative
Selling, general and administrative (“SG&A”) expenses decreased by $815 thousand for the year ended December 31, 2023, as compared to the year ended December 31, 2022. The main factors for the decrease in SG&A expenses for the year ended December 31, 2023 are (i) $96 thousand less insurance expense due to less office space and less employees (ii) less consulting expenses ($196 thousand), and (iii) decrease in various other expenses due to reduction in company size as a result of the Asset Sale.
When an OBJECTIVE investor reads through the 10K's and Q's closely, they can find a LOT of very stinky ingredients.
I still am calling BANKRUPTCY without a MIRACLE.
$AVRW "Seratopical Revolution vs Naked & Thriving: Similarities, Differences & How To Choose The Best Products For You" https://seralabshealth.com/blogs/blog/seratopical-revolution-vs-naked-thriving-similarities-differences-how-to-choose-the-best-products-for-you
@SeralabsHealth @AvenirWellness #OTCQB
Of course it's from 3 years ago. They have NO MONEY to do advertising now.
POM-POMS need to keep posting, so they just regurgitate old stuff.
Pura Vida!!
An Advertisement from 3 years ago that has done "NOTHING" for the share
price..... down over $1.75 per share since that time. Cure Pharmaceutical was
still the company name as they hadn't yet tried to hide all of the bad news
about that company and AVRW didn't even exist. Old stuff - but keep on trying.
Okay, is there anyone out there (besides Student of the Game) who can tell me how long it
will take AVRW to shake off the 10.5MM operating deficit (with continued quarterly losses),
no operating or advertising capital, no way to raise funds (defaulted debt and litigation), an
already ballooned outstanding share count of nearly 78MM and no way to raise more money
through the issuance of shares, and an EPS of (-.06/per share) ?????? Losing money hand over
fist - yet there are people here saying the company is undervalued - holy sheep shit batman.
The only buyers here are those who are already deep in the red hoping for a miracle, and the
occasional gambler here or there who hasn't done their homework and are looking for a quick
flip. This baby is most likely doomed.
It's nearly impossible - that is why I still say BANKRUPTCY LOOMS !!
https://fintel.io/s/us/avrw
https://www.barrons.com/market-data/stocks/avrw
Yes, the measly 105,471 shares traded this WEEK at prices between
.033 and .0519 and a VWAP of .041 indicates a whopping $4,324.31
worth of shares trading hands for the "WEEK". In all relevance, hardly
enough shares to boast about accumulation taking place here on a
penny stock that is virtually unknown.
Why are they unknown? Because they had to change their name 2 times
to try and hide from their past. Cure Pharmaceutical, then SeraLabs, and
Avenir Wellness. When you have litigation against you for defaulted loan
payments - you do anything you can to try and hide it under the rug.
Now, operating off of the CEO's credit card just to make payroll and pay some
of the current bills - well, that doesn't cut it to get the name out about your failing
company. (which at this time is running a $10.5MM deficit - not including the IONIC debt)
Nancy won't mind BANKRUPTCY too much - as she will be the one owed the most
money - and she will probably get receivership as the company will be owing her all
the money AT INTEREST on her credit card. Once the Bankruptcy wipes the other
debts clean - she will be back to having a PRIVATE company again as she had before.
I feel fairly certain that is what they are working on right now.
Nancy Duitch said openly in an interview that she wasn't concerned about share price....
She has no idea how to run a publicly traded company - and by going bankrupt, she will
shed all of the debt (Including the IONIC litigation) which is by now well over 18MM with
interest charges.... and she can go back to doing her website marketing. The shareholder's
will get screwed as usual with MOST PENNY STOCKS..... but Nancy and the company will
survive.
BANKRUPTCY OR MIRACLE ?? - I feel BANKRUPTCY is inevitable.
Nice close at the high of the week for AVRW. More investors are realizing that this stock has plenty of upside reward potential from its current oversold levels and they are accumulating for the long term.
Avenir Wellness Solutions, Inc. AVRW: OTC Markets
At close: 4:00:00 PM ET, 06/28/2024
Last $0.0519 +$0.0019 (+3.80%)
Day High .0519
Day Low .0459
Volume: 13,000
Previous close $0.0500
Today's open $0.0459
All the POM-POMS are out in force today.
DESPERATION!!!
PURA VIDA!!
That's a nice return on an investment from those lows... $AVRW
$AVRW +38.70% in last 90 days: Detailed quote: https://ih.advfn.com/stock-market/USOTC/avenir-wellness-solutions-qb-AVRW/stock-price
$AVRW: How Seratopical Revolution by Nicole Kidman Is Changing The Game
Learn how Nicole Kidman and Nancy Duitch, founder and CEO of SeraLabs and Chief Strategic Officer of CURE Pharmaceutical have joined forces to launch SeraLabs' Seratopical Revolution, a plant-based, alcohol-free, anti-aging beauty line.
Correct, I posted direct links to those facts not all that long ago. Links for NK admitting in public
to botox etc. And then, AVRW boasts about a "plastic surgeon" who recommends the product as
well. ND (CEO) looks totally like she has used his services on many occasions.
There are still some gamblers buying in here.
Have a great day,
PV
Yes, I have to agree. Given what is often written about NK's over injected and toxed visage, what were they expecting with this partnership? When you use a famous face that has obviously benefited from other "interventions" expecting to sell a topical treatment on those coattails is problematic. The document dive reveals what appears to be vast over compensations for key individuals which doesn't seem to gel with the actual success or progress of the company, or maybe I simply don't understand the system well enough. Just my opinion of course.
NICOLE KIDMAN JOINS SERALABS, STOCK HAS TANKED
Nicole Kidman became brand ambassador over 3.5 years ago on Dec. 8th 2020 with the
stock at that time trading for $1.83 per share - (it's 4 cents now).
No one cares that Nicole Kidman uses the products - Barely anyone even knows
who/what SeraLabs & Avenir Wellness and the associated products even are.
They are broke - operating off the CEO's credit card and going further in debt each year.
They have open litigation on defaulted debt, thus the company itself can't even get financing
so they have been depending on the credit card of Nancy Duitch, at interest and going even
further into debt with that.
FACTS AND NUMBERS - BANKRUPTCY LOOMS
https://www.forbes.com/sites/javierhasse/2020/12/08/nicole-kidman-joins-cbd-company-seralabs-we-share-values-around-women-in-business/
AVRW Seratopical skin care products are keeping the famous Nicole Kidman looking her best. Everyone can clearly see this.
When it comes to anti-aging skincare, Kidman's loyalty lies with Seralabs. Kidman, who has been working with the brand since 2020, told InStyle that she “loves using Seratopical because it makes my skin smooth and hydrated.” In honor of the brand ambassador’s birthday, Seralabs is offering 30 percent off sitewide all week with the code NK30.
https://www.instyle.com/nicole-kidman-birthday-favorite-beauty-products-8666305?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons
POM-POMS KEEP PUMPING!!!
$AVRW Brand Ambassador Article out on @Medium "Nicole Kidman Just Turned 57, and I’m Buying Her 5 Go-To Beauty Products" via @SeralabsHealth https://www.instyle.com/nicole-kidman-birthday-favorite-beauty-products-8666305?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons via @InStyle #OTCQB @AvenirWellness
$AVRW Avenir Wellness Solutions, Inc. (OTCQB: AVRW) is undervalued at its current trading levels. Latest Sales Results Show Accelerating Strength via New Marketing Campaigns
For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
Hola Pura Vida. Thanks for your help with understanding all of this. It seems to be quite a rabbit hole. So sorry about your friend.
$AVRW DESCRIPTION: Avenir Wellness Solutions Inc. is a broad platform technology company which develops proprietary wellness, nutraceutical and topical delivery systems. The technology, which is based on current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed. Avenir Wellness Solutions Inc., formerly known as CURE Pharmaceutical Holding Corp., is based in SHERMAN OAKS, CA. www.avenirwellness.com
Hola W11, the 11MM was from the total IONIC loan with A and B convertible notes.
I have the breakdown in one of my past posts from LONG ago. I will go see
if I can dig it up. It is what RD did with IONIC in order to buy out SeraLabs from
ND that put CURE in the mess it found itself in. The revenue generation wasn't
enough and CURE wasn't paying IONIC back thus they began converting notes
like they were going out of style - which of course they did - completely out of
style TANKING the stock price. My buddy lost his ASS and died when the stock
was still trading about 20 cents per share. I think his family just liquidated his
account and thus they lost between 80 and 90K. RD was spinning some wild
tales back then and he, unfortunately fell for them.
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/contract/131571/
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/contract/135876/
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/contract/135877/
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/contract/135878/
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/contract/135879/
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/contract/135880/
https://contracts.justia.com/companies/cure-pharmaceutical-holding-corp-5232/contract/135881/
Have a great rest of the week.
Pura Vida
I have to agree with all your observations. But I don't understand where the 11m figure you mentioned came from. I thought it was 1m with earn outs.
WOO HOO $410 WORTH OF SHARES TRADED
$AVRW +26.54% continuing it's green trading sessions. #Bullish
BUYER BEWARE - LOW VOLUME PENNY STOCK
This penny stock can be easily manipulated. The percentage rise in stock price is
attributable to less than $3,600.00 in total "WEEKLY" trading volume. Some days
it doesn't even trade a single share. Other's a few hundred shares - and other's when
someone wants to "gamble" there might be $2,600.00 in shares traded.
A 2,500 share, $135 trade at 1:46pm is what gave this the whopping 7.8% gain for the day.
Read ALL of the posts before making a decision to gamble on this one. It is definitely
a "RISK" to trade.
$AVRW 0.0539 +7.80% Strong buying to close the week!
Nice buying on AVRW again today. Looks like one more investor decided to take all the .05 shares on the ask that he could get. Little by little the word is getting around that this company is on track for a good growth year in 2024 with higher shareholder value. A while ago shares were available as low as the .03 range. Those who accumulated them should be pleased with the positive pps trend in play now.
The problem with that KP2, RD and Cure Pharma probably aren't generating any sales.
They bought out SeraLabs for 11MM through Nancy Duitch just to show some revenue
generation - which really wasn't quite enough to even cover the debt. He thought that
magically they were going to get both CBD/Cannabis and Magic Mushroom products
generated - but - they didn't get a damn thing done except trigger the A & B Notes from
Ionic by lack of payments to IONIC - the rest is history. Defaulted Debt,
then somehow (through a foreign entity) it appears that RD and ND made a deal for some
reported 20MM for TF Tech Ventures to buy the manufacturing assets and certain key
patents. The BIG still unknown is how Avenir/Cure owed TF Tech Ventures 4.15MM before
that deal was even consummated. The entire mess is ONE MASSIVE STINKING "AFFAIR".
I know you have read all of my past posts and understand that something "VERY STRANGE"
transpired with the marriage of the two companies and subsequent payments, and then
Avenir actually being saddled with the IONIC DEBT. RD is actually free from that but Avenir
didn't pay ANY of the IONIC debt off - thus the litigation.
Anyhow - I wouldn't hold my breath for RD to pay Avenir the balance as his foreign funds probably
dried up, and it is doubtful that the "Mexican" business for the "BLUE BONER STRIPS" is
generating any revenue especially since there are PLENTY OF GENERIC BONER pills available
on the CHEAP these days.
It would be very interesting to see if Avenir is still having Cure manufacture any of the products.....
that Avenir/SeraLabs is selling.
I'm still saying there is a HUGE LACK OF TRANSPARENCY
Sticking with BANKRUPTCY here without a MIRACLE.
Yes, it is quite entertaining to see these posts stating that this stock is undervalued
without giving any details at all to why that might be. There is no mention of the
ongoing rise in the capital deficit to 10.5Million this past year, the defaulted financing
the company accepted from IONIC, then they did not pay it back so IONIC began
converting the A and B notes like they were going out of style and drove the price of
the stock down from over $2.75 per share to about 90 cents before conversions let up.
The drop from 90 cents to the 2 cent level and then the channel between 3 and 4 cents
is just plain and simple - the stock at this MOMENT is actually OVERVALUED by facts
and numbers. This company has never turned a profit, they are currently operating off
of the CEO's credit card, they continue to go in the red each month, they have absolutely
no chance at financing (defaulted debt prohibits that) they have ongoing litigation about
the DEFAULTED DEBT, and they have a huge conflict of interest by having the ex-CEO
being the Chairman of the Board when he himself plunged this company into the debt,
defaulted on that debt by not having enough cash flow after buying SeraLabs, then he
works behind the scenes with a foreign entity to buy back the manufacturing facility and
key patents - and true to his colors, then doesn't pay back ALL of the money owed to
Avenir (which they say, has crippled their ability to expand sales) but somehow.... just
somehow - people are supposed to believe this company is UNDERVALUED ????
Comical.
It’s about time for Mr Davidson to step up to the plate and provide Nancy Duitch with the remaining funds from the sale of the patents!! Mr. Davidson is back at the helm of Cure Pharmaceutical Corp ….and as Chairman of the Board at Avenir Wellness Mr Davidson has access thru Cure Pharmaceutical to provide Avenir with the assistance that’s desperately needed at this time.
POM-POMS need to post; even if they have nothing additive.
Pura Vida!!
$AVRW Avenir Wellness Solutions, Inc. (OTCQB: AVRW) is undervalued at its current trading levels. For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
Yes, OBJECTIVELY, this is going to be interesting.
The 1,823 shares traded today for under $100, that was interesting as well.
Cleaning it up alright.
Gap down at .03 should be filled - seems it always is. Time will tell.
Let's see what the 2nd qtr sales will be.
NO MONEY = NO ADVERTISING = NO SALES. Sales remain flat. Nancy can't promote product without the money to spend (Her credit Card isn't nearly enough!).
DEFAULTED DEBT = NO NEW WAY TO FINANCE
RD BURIED THIS COMPANY, and he still remains Chairman. You don't need to know more than that.
PURA VIDA!!
Objective investors are continuing to see that AVRW is undervalued at its current trading levels and are cleaning up the low offering which is being reflected in the rising pps we have been seeing since the most recent company news.
Some of the most encouraging commentary from AVRW management on the company's true status very good prospects for 2024:
---------------------------------------------------------------------------------------------------------------------------
Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.
Operational Highlights
Other operational highlights during the fourth quarter of 2023 included:
Our newly formulated Seratopical Revolution Cracked Heel Souffle was selected for inclusion in FatFitFun's Summer 2024 subscription box selling out an astonishing 80,000 units in under 43 minutes. Click link to view Instagram videos on our Cracked Heel Souffle.
Our DNA Complex hero product continues to perform as our subscription based grows.
Wholesale sales led by Amazon continue to grow with all the positive product reviews.
We began development of our new TikTok shop to capitalize on the evolving digital ecommerce landscape which launched in the second quarter of 2024.
Source: https://www.accesswire.com/864776/avenir-wellness-solutions-reports-fourth-quarter-2023-results
I would CAUTION those who believe this is in an uptrend to take a look at the
daily chart. Back on April 25th, there was the same type of movement up to the
.0555 level - promptly followed by a sell-off back to the .035 level and then back
down to make a new all time low of .0201 on May 20th. With the present rise in
price - .0545 was briefly touched with a 100 share hit - then it fell back and couldn't reach the
.054 asking price with 19,000 shares sitting at that asking. The bid dropped to
.0407 for 10,000 shares and that was it with the last trade being .05 at 1:12pm and only
21,110 shares traded for the day all of less than $1,000.00 average priced.
This stock is NOT in an upward trend - it is going sideways mostly between .03 and .04
with only two small spikes above .04 which I mentioned above.
In order to state that the stock has broken the sideways channel, .0555 would need to
be taken out and for the price to hold above - followed by a break above the 200 EMA
which is .0605
Don't be fooled by technicals with such a low volume stock - nearly anyone with a couple
thousand dollars can manipulate this stock's technicals with such low volume and low price.
Time will tell - but still calling BANKRUPTCY without a MIRACLE happening.
$AVRW .0545 +11.45% Continued upward trend. #Bullish
Another day of buying and gains for AVRW with the bid and ask prices continuing to move higher.
AVRW - AVENIR WELLNESS SOLUTIONS INC
Last: 0.0489 +0.0069 (+16.4%)
Volume: 72,080
High: 0.0497
Low: 0.0421
Recent Trades - Last 10
Time ET Ex Price Change Volume
15:42:04 Q 0.0489 0.0069 100
15:42:03 Q 0.0497 0.0077 19,799
15:41:28 Q 0.0449 0.0029 100
15:17:00 Q 0.048 0.006 199
15:17:00 Q 0.0449 0.0029 1,200
15:15:18 Q 0.048 0.006 9,800
13:20:46 Q 0.0449 0.0029 500
12:46:57 Q 0.0486 0.0066 17,495
12:46:15 Q 0.0458 0.0038 100
12:45:29 Q 0.0458 0.0038 100
POM-POMS working Over Time!!!
BUYER BEWARE!!!!
PURA VIDA!!!
$AVRW Nice Trading Session Today .044 +37.50% Thin on ASK @ .0488
$AVRW .04 +25.00% Latest Sales Results Show Accelerating Strength via New Marketing Campaigns.
For more information on $AVRW visit: www.avenirwellness.com and www.Seralabshealth.com
Nice day??? Will be a nice day when 500K to 1M shares are traded daily and stock goes to .10 -.15/share. Until then stop with all these craze posts!!
$AVRW .032 X.0438 HOD .045 99k Shares bought on ASK at .0312 earlier.
Don’t see follow through until company has something positive. Don’t trust current management
Let’s see if the buying from today continues….it will take consistent 100,000 plus share volume over an extended period to bid the stock price back up to .10/share. Don’t see that happening without the support of brokerage firms recommending the purchase of Avenir shares.
$AVRW .0489 +25.71% Closing near HOD .049 #Bullish
Followers
|
35
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3790
|
Created
|
11/14/16
|
Type
|
Free
|
Moderators ProfitScout Dickmo jedijazz greendolphin11 Student of the Game BlazingStocks |
Avenir Wellness Solutions (OTC: AVRW)
Formerly CURE Pharmaceutical (OTC: CURR)
For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
COMPANY UPDATE:
Press Release | 02/13/2024
Link: https://feeds.issuerdirect.com/news-release.html?newsid=6554360501139897
Brand New Avenir Wellness DNA Product: https://seralabshealth.com/products/dna-complex
CEO INTERVIEW on Apple Podcasts:
"Lifetime of Health and Wellness - Nancy Duitch, CEO The Sera Labs"
Host April Franzino is joined by:
Nancy Duitch, CEO of The Sera Labs (see image below).
"Nancy discusses how she has spent her entire career working on solution-based health, wellness and beauty products to help people look and feel their absolute best."
Instagram: https://www.instagram.com/beautybizshow/
See omnystudio.com/listener for privacy information.
AVENIR WELLNESS: BUILDING INOVATIVE WELLNESS TECHNOLOGIES FOR THE FUTURE
Avenir Wellness is a vertically integrated drug delivery and development company
Committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage
Spokesperson Nicole Kidman, Actor (see image below).
Visit the Seratopical Store on AMAZON
LINK: https://www.amazon.com/stores/SERATOPICAL/page/473637CB-F4D4-470C-B60D-7B3885CDED6E?ref_=ast_bln
The plant based, alcohol-free, non-CBD, anti-aging beauty line is available Wednesday, June 9
Sera Labs, a subsidiary of Avenir Wellness Solutions, announced a new ad campaign and launch of Seratopical Revolution, a new clean, plant-based, technologically advanced, anti-aging, ‘revolutionary,’ beauty line.
Nicole Kidman and Sera Labs Inc., an Avenir Wellness Solutions Company, launch Seratopical Revolution. (Photo: Business Wire)
The line touts 11 luxurious products which are all are made in the U.S., available at accessible pricing, and are designed to make you feel more youthful and hydrated from head to toe. Award-winning actress Nicole Kidman, Sera Labs’ strategic business partner and global brand ambassador, collaborated with Sera Labs to design the Loving Hands Essential Oil , Indulgence Brown Sugar Scrub , Harmony Face & Neck Toner , and Gleaming for the ultimate brightening glow. The full line of products can be seen at Seratopicalrevolution.com .
“I really wanted to create something that was meaningful to me and that I knew people would genuinely enjoy,” said Kidman, Seratopical strategic business partner and global brand ambassador. “These products are personal to me from the scent to the texture. I am so excited to share them with the world and hope everyone loves them as much as we do.”
Seratopical Revolution marries nature and science into one clean and nourishing line of beauty products. The line’s P?P complex, developed by CURE Pharmaceutical, drives natural, plant-based ingredients into the deeper layers of the skin by utilizing a proprietary tri-peptide delivery system. Unlike other companies that use alcohol as a delivery system, which is incredibly drying to the skin, Seratopical Revolution’s natural oil and surfactant delivery systems are efficacious and offer almost immediate results.
“It’s been an incredible ride creating this line with Nicole,” said Nancy Duitch , Sera Labs CEO and CURE Pharmaceutical Chief Strategic Officer. “There are a lot of beauty companies, but the problem is that most of them don’t understand that without an effective delivery system, the products are sitting on top of your skin and clogging your pores. Our proprietary formulators have developed a high-tech delivery system which allows the ingredients to go deep into the skin. Our loyal customers will benefit from scientifically backed ingredients that are designed to enhance hydration and rejuvenate collagen. Revolution offers a full-body line packed with natural plant extracts and peptide blends.”
Seratopical Revolution products can be purchased online at seratopicalrevolution.com
Ad campaign photo and product images: https://www.dropbox.com/sh/o8l39o5xb0yj4bs/AAAj1WTWRwK05EpziP4BJn7ka?dl=0
For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Sera Labs
Sera Labs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD and clean plant-based products. Sera Labs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names Seratopical ™, SeraLabs™, and Gordon’s Herbals™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness. Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions. For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Avenir Wellness Solutions Company
Avenir Wellness is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a vertically integrated company, AVRW’s 25,000 square foot, FDA-registered, NSF® cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. Avenir has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210609005442/en/
Avenir Wellness [OTC: AVRW] and Canopy Growth to Produce CBD Oral Thin Films
AVRW has an FDA- and DEA- registered, GMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform™ includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system.
AVRW names Canopy Rivers Chairman John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to the company, most recently serving as chairman of the Canopy Rivers board of directors and former chairman of Canopy Growth’s board of directors.
AVRW offers combined technologies that provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. AVRW partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets. The AVRW company mission is to improve people’s lives by redefining how medicines are delivered and experienced.
AVRW Products Fall Into Two Categories: Nutraceuticals (dietary supplements) and Pharmaceutical Medicines
Nutraceuticals:
CUREfilm® Sleep is a daily dietary supplement that delivers a unique blend of five active ingredients with the CUREfilm® platform to promote healthy sleep patterns. This product is launched in U.S. markets.
CUREfilm® D is a high-potency dietary supplement that provides 50,000 IU of Vitamin D3 delivered with the CUREfilm® platform.
CUREfilm™ Hemp delivers hemp extracts via the CUREfilm® dosage form. This product is launched in U.S. markets.
CUREfilm® β-Caryophyllene is a dietary supplement that contains 30mg of β-Caryophyllene, a powerful terpene known for its anti-inflammatory and analgesic properties.
Pharmaceuticals:
CUREfilm® Blue contains 50mg of Sildenafil delivered with the CUREfilm® platform.
CUREfilm® Canna delivers synthetic and plant-derived cannabinoids in an oral thin film for pharmaceutical indications.
AVRW Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
On February 5th AVRW announced that it had signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s leading pharmaceutical groups specialized in medicinal cannabis products. The agreement grants ReLeaf Europe exclusive access to the AVRW encapsulation technology for certain oral and topical cannabis products in the Netherlands, the world’s first medical cannabis market. ReLeaf Europe products will be the first to use the CUREinside™ quality mark to bolster consumer confidence. Europe is one of the world’s largest medical cannabis markets due to various governments’ approval for medicinal purposes.
ReLeaf Europe is one of the few pharmacy providers of pharmaceutical-grade medicinal cannabis oils in Europe and an ideal partner for the AVRW first step into the European market because of its commitment to establishing clinical evidence and following EU GMP and GDP standards. Through this agreement, AVRW will roll out its powered by CURE strategy that includes exclusive licensing relationships to build global market share.
ReLeaf Europe is tackling the largest market in the world for cannabis by establishing a foothold in Holland — a market estimated to reach $2.6B by 2028 — and by pursuing innovative delivery systems and distribution networks. AVRW will power several ReLeaf Europe products, including one sublingual tincture and two topical creams to be launched in 2020.
Major Earnings Potential in the Emerging Medicinal Cannabis Industry
The Cannabis plant has an estimated 113 different compounds, out of which THC and CBD are the two main constituents. THC is mainly responsible for the psychoactive effects or the
feeling of “high” caused by the use of cannabis. CBD on the other hand, has several powerful anti-inflammatory, analgesic, neuroprotective and anti-anxiety properties, which explains its growing popularity to treat a plethora of medical conditions. Unlike THC, CBD does not have any psychotropic effects and hence is widely preferred.
CBD is now being used to treat a wide array of medical conditions such as cancer, cardiovascular anomalies, arthritis, anxiety, depression and Insomnia. In addition, it has also been proven to possess neuroprotective benefits that can treat diseases such as seizures, Multiple Sclerosis (MS), Alzheimer’s, Parkinson’s and Schizophrenia to name a few. There is a growing preference for CBD over traditional pharmaceutical options as these have minimal side effects and are non-addictive.
The global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand View Research, Inc, growing at a CAGR of 23.9%. There is a growing acceptance of the curative effects of cannabis, with some countries such as Canada and certain states of U.S legalizing the use of Marijuana for medical and recreational use. Research has time and again shown that cannabinoids (CBD), extracted from the cannabis plant, have varied medical uses with minimal side effects, making it a sought-after alternative to traditional pharmaceutical options.
AVRW has signed a licensing and collaboration agreement with
Vanguard Scientific Systems, Inc.
Vanguard is a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE’s patented cannabis extraction methods, providing customer confidence in choosing Vanguard’s portfolio of extraction manufacturers
The industry is poised to grow to $2.1 billion in 2020, a 700% increase from 2016. Those numbers are not only appealing to the players in the CBD market but also serve as an incredible opportunity the pharmaceutical companies to create novel solutions for disease with large unmet medical needs. AVRW is strategically positioned with multiple high value assets and extremely well-placed marketing partners to optimize the company’s earnings potential in the growing fields of key drug supply and delivery solutions, including the multi-billion-dollar CBD marketplace. For more information on Avenir Wellness (OTCQB: AVRW ) visit: http://www.avenirwellness.com
Company News
02/13/2024 Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and
Facial Plastic Surgeon Dr. Michael Persky
09/19/2023 Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market
08/08/2023 Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
05/17/2023 Avenir Wellness Solutions Update to Stockholders
04/28/2023 New to The Street Announces the Televised Lineups for Shows 461, 462, and 463; Airings on Three Networks Will Begin on Saturday, April 29, 2023, at 3:30 PM ET
04/26/2023 Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
04/25/2023 Avenir Wellness Letter to Stockholders
04/13/2023 New to The Street Announces the Televised Lineups for Shows 452, 457, and 458, Airings on Three Networks Will Begin Tonight, Thursday, April 13, 2023, at 9:30 PM ET
DISCLAIMER:
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |